Top Suppliers:I want be here


341519-04-8

341519-04-8 structure
341519-04-8 structure

Name H-p-Chloro-Phe-D-Cys-β-(3-pyridyl)-Ala-D-Trp-N-Me-Lys-Thr-Cys-2-Nal-NH2
Synonyms H-p-Chloro-Phe-D-Cys-b-(3-pyridyl)-Ala-D-Trp-N-Me-Lys-Thr-Cys-2-Nal-NH2
Description PRL 3195 is a somatostatin receptor antagonist with Kis of 6, 17, 66, 1000 and 1000 nM for human somatostatin receptors (sst5, sst2, sst3, sst1 and sst4, respectively)[1].
Related Catalog
Target

hsst5:6 nM (Ki)

hsst2:17 nM (Ki)

hsst3:66 nM (Ki)

hsst1:1000 nM (Ki)

hsst4:1000 nM (Ki)

rat urotensin II receptor:429 nM (Ki)

human urotensin II receptor:1846 nM (Ki)

In Vitro PRL 3195 抑制人尿紧素 II (human urotensin II) 诱导的大鼠主动脉相位振荡,ED50 为 24 nM[1]。
References

[1]. Rossowski WJ, et al. Human urotensin II-induced aorta ring contractions are mediated by protein kinase C, tyrosine kinases and Rho-kinase: inhibition by somatostatin receptor antagonists. Eur J Pharmacol. 2002 Mar 8;438(3):159-70.  

Molecular Formula C58H71ClN12O9S2
Molecular Weight 1179.84000
Exact Mass 1178.46000
PSA 416.55000
LogP 6.00420
The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.